Health
Dengue ‘will take off’ in southern Europe, US and Africa this decade
Dengue will become a major threat in the southern United States, southern Europe and new parts of Africa this decade, according to the WHO’s chief
U.S. plans to move Merck’s COVID drug to the commercial market
The US government will stop distributing free doses of Merck & Co’s COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it
Mexico has reported H5N1 avian influenza in wild ducks
Mexican animal safety authorities confirmed the first case of H5N1 bird flu in wild birds on Wednesday after declaring the country’s poultry farms free of
Britain proposes to ban cigarettes from the younger generation
The British government on Wednesday proposed banning the younger generation from ever buying cigarettes. The move would create some of the world’s toughest smoking regulations
Amgen data on late-stage lung cancer drug ‘inadequate’
US Food and Drug Administration experts said Amgen’s late-stage trial may not be sufficient to confirm the effectiveness of its lung cancer drug, as the
US FDA authorises updated Novavax vaccine for COVID
The U.S. Food and Drug Administration said Tuesday it has approved an updated version of Novavax’s COVID-19 vaccine for emergency use in individuals aged 12
India discovers more toxic syrups after poisoning deaths
India’s drug regulator has found that a cough syrup and anti-allergy syrup made by Norris Medicines are toxic, according to a government report, months after
WHO recommends a malaria vaccine
The World Health Organisation recommended on Monday the use of a second malaria vaccine to curb the life-threatening disease transmitted to humans by some mosquitoes.
AstraZeneca to pay $425m to settle Nexium and Prilosec dispute in US
British drugmaker AstraZeneca said Tuesday it will pay $425 million to settle product liability litigation against the prescription-only acid reflux drug Nexium and heartburn drug
Sanofi reaches agreement with Janssen to develop E. coli vaccine
Sanofi announced that it had reached an agreement with Janssen to develop and commercialise a vaccine candidate against extraintestinal pathogenic E. coli. Under the terms